These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23794673)

  • 1. Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?
    Sorkin GC; Dumont TM; Wach MM; Eller JL; Mokin M; Natarajan SK; Baxter MS; Snyder KV; Levy EI; Hopkins LN; Siddiqui AH
    J Neurointerv Surg; 2014 Jun; 6(5):373-8. PubMed ID: 23794673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting.
    Sakai N; Yamagami H; Matsubara Y; Ezura M; Hyodo A; Matsumaru Y; Miyachi S; Okada Y; Terada T; Yokoi H; Nakamura M; Matsumoto Y; Sakai C;
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1374-84. PubMed ID: 24534127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effects of clopidogrel dose adjustment (75 mg/d vs 150 mg/d) after carotid stenting.
    González A; Moniche F; Cayuela A; Gonzalez-Marcos JR; Mayol A; Montaner J
    J Vasc Surg; 2014 Aug; 60(2):428-35. PubMed ID: 24629989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting.
    Bhatt DL; Kapadia SR; Bajzer CT; Chew DP; Ziada KM; Mukherjee D; Roffi M; Topol EJ; Yadav JS
    J Invasive Cardiol; 2001 Dec; 13(12):767-71. PubMed ID: 11731685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
    Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
    J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
    Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
    J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
    Nakagawa I; Park HS; Wada T; Yokoyama S; Yamada S; Motoyama Y; Kichikawa K; Nakase H
    Neurol Res; 2017 Aug; 39(8):695-701. PubMed ID: 28290236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting.
    Kim BJ; Kwon JY; Jung JM; Lee DH; Kang DW; Kim JS; Kwon SU
    J Neurosurg; 2014 Oct; 121(4):891-8. PubMed ID: 25036195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional patterns of clopidogrel response among patients undergoing transcarotid artery revascularization.
    Rokosh RS; Rockman C; Garg K; Wang SK; Motaganahalli RL; Schroeder AC; Sobraske PJ; Stoner MC; Tarbunou YA; Marmor RA; Malas MB; Maldonado TS
    Vascular; 2024 Jun; 32(3):558-564. PubMed ID: 36428145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.
    Giustino G; Redfors B; Kirtane AJ; Mehran R; Dangas GD; Witzenbichler B; Neumann FJ; Weisz G; Généreux P; Maehara A; McAndrew T; Farhan S; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Gurbel P; Ben-Yehuda O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1277-1286. PubMed ID: 29908967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.
    Alcocer F; Novak Z; Combs BR; Lowman B; Passman MA; Mujib M; Jordan WD
    J Vasc Surg; 2014 Apr; 59(4):950-5. PubMed ID: 24491238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid artery stenting in octogenarians is associated with increased adverse outcomes.
    Stanziale SF; Marone LK; Boules TN; Brimmeier JA; Hill K; Makaroun MS; Wholey MH
    J Vasc Surg; 2006 Feb; 43(2):297-304. PubMed ID: 16476605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
    Markus HS; Droste DW; Kaps M; Larrue V; Lees KR; Siebler M; Ringelstein EB
    Circulation; 2005 May; 111(17):2233-40. PubMed ID: 15851601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting.
    Jin HY; Yang TH; Kim DI; Chung SR; Seo JS; Jang JS; Kim DK; Kim DK; Kim KH; Seol SH; Nam CW; Hur SH; Kim W; Park JS; Kim YJ; Kim DS
    Int J Cardiol; 2013 Sep; 167(5):1877-81. PubMed ID: 22682702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests.
    Woo KS; Kim BR; Kim JE; Goh RY; Yu LH; Kim MH; Han JY
    Korean J Lab Med; 2010 Oct; 30(5):460-8. PubMed ID: 20890076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2Y12 platelet reactivity after thrombolytic therapy for ST-segment elevation myocardial infarction.
    Diego A; de Prado AP; Cuellas C; de Miguel A; Samaniego B; Alonso-Rodríguez D; Bangueses R; Vega B; Martín J; Fernandez-Vazquez F
    Thromb Res; 2012 Sep; 130(3):e31-6. PubMed ID: 22704077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
    Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of carotid artery stenting versus historical surgical controls for radiation-induced carotid stenosis.
    Tallarita T; Oderich GS; Lanzino G; Cloft H; Kallmes D; Bower TC; Duncan AA; Gloviczki P
    J Vasc Surg; 2011 Mar; 53(3):629-36.e1-5. PubMed ID: 21216558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urgent carotid artery stenting with technical modifications for patients with transient ischemic attacks and minor stroke.
    Moratto R; Veronesi J; Silingardi R; Sacha NM; Trevisi Borsari G; Coppi G; Coppi G
    J Endovasc Ther; 2012 Oct; 19(5):627-35. PubMed ID: 23046328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.